Author
Ligong Chen
Capital Medical UniversityORCID 0000-0002-7893-7173Unclaimed ORCID profile · follow to get notified of new preprints
Additional preprints under this name without ORCID
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2017-2025 · peak 1/yrCo-Author Collaboration Network
10 top collaborators · 29 mutual co-author linksFocal author (center)Selected co-authorORCID co-authorUnlinked name
Curved chords = mutual co-authorship3 papers
Recent·Most cited
- Systems BiologySignal Transduction and Targeted TherapyPeer-reviewed
A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
Yiyue Ge, Tingzhong Tian, Suling Huang…·Jianyang Zeng
This paper presents a data-driven drug repositioning framework that identifies CVL218, a PARP1 inhibitor, as a potential therapeutic for COVID-19 through in silico and experimental validation.
300 citationstop 1% - BioinformaticsNature CommunicationsPeer-reviewed
A Network Integration Approach for Drug-Target Interaction Prediction and Computational Drug Repositioning from Heterogeneous Information
Yunan Luo, Xinbin Zhao, Jingtian Zhou…·Jianyang Zeng
This paper introduces DTINet, a network integration method for predicting drug-target interactions and repositioning drugs, showing improved performance and validated novel COX inhibitor applications.
924 citationstop 1%